Rosacea Support protocol

Rosacea Support

skin conditionsemerging evidence

About this protocol

Rosacea is a chronic inflammatory facial dermatosis affecting roughly 5% of adultsdisproportionately women aged 30-60 with fair skin (Fitzpatrick I-II), though it occurs across all skin types and is frequently underdiagnosed in darker skin. It presents as four overlapping phenotypes: erythematotelangiectatic (persistent central facial redness with visible vessels), papulopustular (acne-like inflammatory papules and pustules), phymatous (skin thickening and tissue overgrowth, most often on the nose), and ocular (dry, gritty, inflamed eyesfrequently missed because patients see ophthalmology and dermatology separately). The pathology is multifactorial: dysregulated innate immunity via the cathelicidin/LL-37 pathway, mast cell activation, neurovascular hyperresponsiveness, and Demodex folliculorum mite overgrowth all interact. The first-line conventional toolkittopical metronidazole, ivermectin (Soolantra), azelaic acid, and brimonidine; oral sub-microbial doxycycline; isotretinoin for refractory phymatous diseaseis genuinely effective and should not be skipped in favor of supplements. Supplements occupy a narrower supportive role here than in eczema or psoriasis. The trial evidence is thinner, and the most impactful daily actions are trigger identification, photoprotection, and gentle skincarenot a pill regimen. We've included supplements with at least some direct rosacea evidence (oral zinc, niacinamide) plus a few with strong mechanistic rationale (omega-3 for ocular subtype, quercetin for mast cell stabilization). If your rosacea is moderate-to-severe, scarring, or involves the eyes, see a dermatologist (and an ophthalmologist for ocular involvement) — topical ivermectin and oral doxycycline transformed outcomes in the last decade and remain the backbone of treatment.

Where to start

Triggers matter more than supplements. Before adding anything from this stack, spend 4-6 weeks keeping a trigger journal. The most consistent rosacea triggers are heat (hot drinks, hot showers, hot weather, exercise), sun exposure, alcohol (red wine especially), spicy food, stress, extreme cold/wind, and certain skincare ingredients. Identifying and removing your personal triggers will outperform any supplement on this list.

Start with oral niacinamide at 500 mg twice daily. The strongest topical evidence is for niacinamide-containing moisturizers (Draelos 2005 showed barrier improvement in rosacea), but oral niacinamide also modulates inflammation and supports barrier function. Pair with a topical niacinamide moisturizer for compound effect.

Add zinc at 30-50 mg elemental daily, taken with food. The Sharquie 2006 placebo-controlled trial used 100 mg zinc sulfate three times daily (about 100 mg elemental) and showed clinically meaningful improvement, but that dose causes significant GI upset and risks copper deficiency over time. A more sustainable 30-50 mg/day with breakfast captures most of the anti-inflammatory effect with far less GI burden.

Consider omega-3 EPA-dominant at 2 g combined daily if you have ocular rosacea, dry-eye symptoms, or meibomian gland dysfunction. The Bhargava 2013 RCT showed omega-3 improved tear film and ocular surface metrics, with the strongest signal in blepharitis and meibomian gland diseasethe same mechanisms driving ocular rosacea.

Treat quercetin as experimental. Mast cell activation is now recognized as a key driver in rosacea (Muto 2014), and quercetin stabilizes mast cells more effectively than cromolyn in vitro (Weng 2012). Trial evidence in rosacea specifically is absent. If flushing or vascular reactivity is your dominant symptom, a 250-500 mg twice-daily trial for 8-12 weeks is reasonable; if no change, drop it.

See a dermatologist if any of the following apply: persistent papules/pustules unresponsive to OTC care, visible vessels you want treated (vascular laser or IPL), eye involvement (gritty, burning, recurrent styes), rhinophyma or early phymatous changes, or symptoms affecting your quality of life or self-image. Topical ivermectin (Soolantra), azelaic acid, brimonidine, and oral sub-microbial doxycycline are the high-value prescription tools.

Re-evaluate at 12 weeks. If your trigger journal plus this stack hasn't reduced flare frequency or background redness, the bottleneck is almost certainly topical/prescription rather than nutritional.

4 nutrients

Start here

Strongest evidence — the foundation of the stack.

Niacinamide (Nicotinamide)

500 mg twice daily with food (avoid niacin/nicotinic acid — it causes flushing, which is exactly what you don't want in rosacea)
morningwith food

Niacinamide modulates inflammation by inhibiting NFB signaling, supports ceramide biosynthesis in the stratum corneum (Tanno 2000), and has direct effects on sebum regulation. The strongest evidence in rosacea is for topical niacinamide moisturizers (Draelos 2005 showed clinical benefit on barrier function and patient-rated outcomes in 50 rosacea subjects), and oral niacinamide is mechanistically aligned but has thinner direct-rosacea trial data. CRITICAL: use niacinamide (nicotinamide), NOT niacin (nicotinic acid). Niacin causes prostaglandin-D2 mediated cutaneous flushingexactly the opposite of what a rosacea patient wants. Topical niacinamide-containing moisturizers (often labeled 4-5% niacinamide) layer well with oral supplementation.[1, 2, 3, 4]

Zinc (Picolinate or Gluconate)

30-50 mg elemental zinc daily with breakfast; cycle in copper (1-2 mg) if used long-term
morningwith food

Zinc has direct anti-inflammatory effects, supports skin barrier protein synthesis, and modulates innate immunityincluding the cathelicidin pathway implicated in rosacea pathophysiology. The Sharquie 2006 randomized double-blind placebo-controlled crossover trial used oral zinc sulfate 100 mg three times daily and showed statistically significant reduction in rosacea severity versus placebo, with GI upset in only 12% of subjects. We dose lower (30-50 mg elemental) for better long-term tolerance and to avoid copper depletion. Effect builds over 8-12 weeks. If you're already taking zinc for another reason, don't stacktotal elemental zinc above 40 mg/day chronically requires copper supplementation.[5, 6]

Add if needed

Add these only if the foundation isn't enough.

Omega-3 (EPA-dominant fish oil)

2 g combined EPA+DHA daily (EPA-dominant), with a fat-containing meal — especially if ocular rosacea or dry-eye symptoms
morningwith food

Omega-3 EPA/DHA reduces pro-inflammatory eicosanoid production and supports the lipid composition of meibomian gland secretionsthe gland dysfunction at the heart of evaporative dry eye and ocular rosacea. The Bhargava 2013 RCT (518 dry-eye patients, 3 months) found omega-3 improved Schirmer test, tear breakup time, and conjunctival impression cytology versus placebo, with the strongest signal in blepharitis and meibomian gland disease. For cutaneous rosacea, the evidence is more indirectgeneral anti-inflammatory effect rather than rosacea-specific trial data. Highest-value indication: rosacea patients with ocular involvement (gritty eyes, recurrent styes, blepharitis).[7, 8]

Experimental

Emerging evidence — try last, only if curious.

Quercetin

250-500 mg twice daily with food, often paired with bromelain or vitamin C for absorption
morningwith food

Mast cells are now recognized as central effectors of rosacea-associated inflammation: Muto 2014 demonstrated that mast cells mediate cathelicidin-initiated skin inflammation in murine rosacea models, and mast cell counts are elevated in human rosacea-affected skin. Quercetin is a flavonoid mast cell stabilizer; the Weng 2012 study showed it outperformed cromolyn in suppressing human mast cell cytokine release and improved contact dermatitis and photosensitivity in small human trials. However, NO controlled trial has tested quercetin in rosacea directly. The mechanism is plausible and the safety profile is favorable, but treat this as exploratory. Most useful target: patients whose dominant symptom is flushing or environmental reactivity rather than persistent papules.[9, 10, 11]

Warnings

Do not take with: Topical or oral retinoids (vitamin A is fat-soluble; do not stack supplemental vitamin A on top of prescription isotretinoin or tretinoin therapyrisk of hypervitaminosis A). Anticoagulants and antiplatelets (omega-3 at high doses may modestly increase bleeding risk; quercetin has weak antiplatelet effect). Niacin / nicotinic acid (do NOT substitute for niacinamideniacin causes prostaglandin-D2 mediated cutaneous flushing, the opposite of the goal). Cyclosporine and tacrolimus (quercetin inhibits CYP3A4 and may raise levelsdiscuss with prescriber). Brimonidine topical (no direct interaction, but rebound erythema is a real concern with brimonidinesupplements won't prevent it).
Do not take if: You are pregnant or breastfeeding (zinc and omega-3 at typical doses are generally considered safe; high-dose niacinamide and quercetin have less datadiscuss with your obstetrician). You are taking prescription isotretinoin (Accutane) — high-dose vitamin A from supplements is contraindicated and the dermatologist managing your treatment should also be told you are using this stack. You have severe ocular rosacea with corneal involvementthis is an ophthalmologic urgency, not a supplement problem; see a cornea specialist. You have rhinophyma or significant phymatous changesthese typically require procedural treatment (laser, electrosurgery, surgical debulking) and supplements will not reverse established tissue changes. You have a known fish or shellfish allergy (use algal-derived omega-3). You have hemochromatosis or are on iron chelation therapy (zinc and copper balance becomes more complexcoordinate with hematology).

Lifestyle improvements

Identify your triggers — this is the single highest-leverage action

Keep a 4-8 week flare journal noting food, drink, weather, skincare products, stress, and any flushing or worsening within 30-60 minutes. The most commonly reported rosacea triggers, drawn from National Rosacea Society surveys and clinical experience: sun exposure (#1 cited trigger), emotional stress, hot weather, alcohol (red wine in particular), spicy food, heated beverages (coffee, tea), exercise-induced overheating, cold wind, certain skincare ingredients (alcohol-based toners, strong AHAs/BHAs, fragrance, witch hazel), and humid heat. Your personal trigger profile matters more than any general listthe pattern in your own journal beats the average.

Daily mineral SPF 30+ — non-negotiable

UV is the most consistently identified rosacea trigger, and chronic UV exposure worsens telangiectasia and erythema. Use a broad-spectrum SPF 30 or higher every morning, year-round, even in winter and on cloudy days. Mineral (zinc oxide, titanium dioxide) sunscreens are usually better tolerated than chemical filters on rosacea-prone skinchemical filters can sting and trigger flushing. Tinted mineral sunscreens add iron oxides that block visible light (relevant for melasma and post-inflammatory pigmentation in skin of color). Reapply if outdoors for extended periods.

Gentle skincare — strip the routine down

Rosacea skin reacts poorly to active ingredients that work fine on neutral skin. Eliminate: alcohol-based toners, fragranced cleansers, witch hazel, strong glycolic/salicylic acid, retinol unless prescribed and titrated by your dermatologist, physical scrubs, brushes, and hot water on the face. Keep: a fragrance-free non-foaming gentle cleanser, a barrier-supporting moisturizer (look for ceramides, glycerin, niacinamide, panthenol), and mineral sunscreen. That's the entire routine for most rosacea patients. Adding actives back in is something to negotiate with a dermatologist, slowly.

Lukewarm water on the face, always

Hot water dilates facial vessels and triggers flushing. Wash with lukewarm or cool water, pat dry, apply moisturizer while skin is still slightly damp. Skip facial saunas, steam treatments, and very hot showers angled at the face.

Reduce alcohol — especially red wine — if it's a trigger

Alcohol is one of the most commonly reported triggers, and red wine specifically contains histamine and tyramine that drive flushing beyond ethanol's vasodilatory effect. You don't necessarily have to abstainbut track it in your trigger journal. Many rosacea patients tolerate spirits or white wine better than red. If alcohol consistently triggers a 24-72 hour flare, the cost-benefit calculus changes.

Spicy food and hot drinks — case by case

Capsaicin activates TRPV1 receptors in facial vasculature and triggers flushing in susceptible individuals. Hot drinks (coffee, tea) trigger via temperature, not caffeineiced coffee usually doesn't flare. If your journal flags either, modify; if not, don't restrict unnecessarily.

Address ocular hygiene if you have ocular subtype

Ocular rosacea is underdiagnosed and undertreated. If your eyes feel gritty, burn, water excessively, or you get recurrent styes/chalazia: warm compresses (a clean washcloth at warm-not-hot temperature for 5 minutes, twice daily), gentle lid hygiene with a dedicated lid cleanser (hypochlorous acid spray or diluted baby shampoo), and an ophthalmology referral. Omega-3 supplementation is genuinely useful here (Bhargava 2013). Severe ocular rosacea may need oral doxycycline.

Stress management — real, not optional

Stress is one of the top three reported triggers. Daily breathwork, regular aerobic exercise (in a cool environment), CBT for chronic skin disease, and treating coexisting anxiety/depression all reduce flare frequency. Rosacea has measurable quality-of-life and self-esteem impactaddressing it is part of the treatment, not a soft add-on.

Discuss prescription topicals with a dermatologist

The high-value prescription tools, in rough order of impact: topical ivermectin (Soolantra) addresses the Demodex component and reduces papulopustular lesions; topical metronidazole and azelaic acid are first-line for inflammatory papules; brimonidine reduces background erythema (but watch for rebound); oral sub-microbial doxycycline (Oracea 40 mg) for moderate inflammatory disease without antibiotic effect; vascular laser or IPL for persistent telangiectasia. Supplements are complementary to these, not a substitute.

Don't ignore phymatous changes

Early phymatous rosacea (thickening skin on the nose, chin, cheeks, ears) is more treatable than late. If you notice gradual skin thickening, see a dermatologistearly oral isotretinoin or procedural treatment changes the trajectory. Established rhinophyma typically requires laser or surgical debulking.

References

  1. Niacinamide — supplement research overviewExamine.com link
  2. Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76(2):135-141.PubMed link
  3. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143(3):524-531.PubMed link
  4. Boo YC. Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants (Basel). 2021;10(8):1315.PubMed link
  5. Zinc — supplement research overviewExamine.com link
  6. Sharquie KE, Najim RA, Al-Salman HN. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. Int J Dermatol. 2006;45(7):857-861.PubMed link
  7. Fish oil — supplement research overviewExamine.com link
  8. Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol. 2013;6(6):811-816.PubMed link
  9. Quercetin — supplement research overviewExamine.com link
  10. Weng Z, Zhang B, Asadi S, et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One. 2012;7(3):e33805.PubMed link
  11. Muto Y, Wang Z, Vanderberghe M, Two A, Gallo RL, Di Nardo A. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014;134(11):2728-2736.PubMed link
  12. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):S15-S26.PubMed link
  13. van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol. 2019;181(1):65-79.PubMed link

Related protocols

Other skin conditions protocols and protocols sharing ingredients with this one.

Eczema Support

skin conditions

Atopic dermatitis (eczema) is a chronic, relapsing inflammatory skin disease affecting 10-20% of children and 1-3% of adults. The pathology is a tripod: skin barrier dysfunction (often driven by filaggrin gene mutations), Th2-skewed immune dysregulation, and an altered skin microbiome with reduced diversity and Staphylococcus aureus overgrowth. Flares cycle around triggers — irritants, allergens, stress, infection, dry climate — and conventional treatment is rightly aggressive in moderate-to-severe disease: daily emollients, topical corticosteroids and calcineurin inhibitors (tacrolimus, pimecrolimus), and for refractory or extensive disease, biologics like dupilumab. Supplements occupy a supportive role here. They can blunt systemic inflammation, support barrier function, and nudge immune balance — but they don't replace the topical and systemic backbone. If your eczema is moderate-to-severe, scarring you, disrupting sleep, or unresponsive to good topical care — see a dermatologist. Modern biologics (dupilumab, tralokinumab) have transformed outcomes for adult atopic dermatitis. Supplements work best as one layer of a multi-modal plan that always includes daily emollient routine and trigger management.

Psoriasis Support

skin conditions

Psoriasis is a chronic, immune-mediated inflammatory disease affecting 2-3% of adults. The hallmark is accelerated keratinocyte turnover — skin cells replicating every 3-5 days instead of the normal 28-30 — driven by a Th17/IL-23 immune axis. Clinically that shows up as well-demarcated red plaques with silvery scale, classically on the elbows, knees, scalp, and lower back. Psoriasis is not just a skin disease: it carries substantial comorbid risk. Roughly 30% of patients develop psoriatic arthritis, and the cohort as a whole runs higher cardiovascular disease, metabolic syndrome, and depression rates than the general population. Treatment is genuinely multi-modal — topical corticosteroids and vitamin D analogs (calcipotriol) for limited disease, phototherapy for wider involvement, and systemic biologics targeting IL-17 (secukinumab/Cosentyx), IL-23 (risankizumab/Skyrizi, guselkumab/Tremfya, ustekinumab/Stelara), or TNF-alpha (adalimumab/Humira) for moderate-to-severe disease. If you have moderate-to-severe psoriasis — significant body surface area, scalp/genital/palmar-plantar involvement, joint symptoms, or quality-of-life impact — see a dermatologist. The biologics era has been transformative; PASI 90 (90% lesion clearance) is now a realistic goal for most patients, not the exception. Supplements occupy a supportive role: they can blunt systemic inflammation, correct deficiencies that worsen disease activity, and address the cardiometabolic comorbidity burden. They don't replace appropriate dermatologic care for anything beyond mild localized disease.

Fibromyalgia Support

chronic illness· 1 shared ingredient

Fibromyalgia is a real, frequently-dismissed condition affecting an estimated 2-4% of adults — predominantly women between 30 and 60. Its core features are chronic widespread musculoskeletal pain, fatigue, cognitive dysfunction (commonly called "fibro fog"), non-restorative sleep, and frequent comorbidities including IBS, anxiety, and depression. The dominant pathophysiologic model is central sensitization — the central nervous system amplifies pain signals — and a subset of patients also show small-fiber neuropathy on skin biopsy. Mitochondrial dysfunction and oxidative stress are increasingly documented in the fibromyalgia literature. CRITICAL: This protocol is ADJUNCTIVE. Fibromyalgia management is multi-modal, and supplements are one part of a larger plan. Conventional medications (duloxetine, pregabalin, amitriptyline, milnacipran), cognitive behavioral therapy adapted for fibromyalgia (CBT-FM), gentle aerobic exercise as tolerated, and aggressive sleep optimization all have stronger evidence individually than any supplement. That said, fibromyalgia is one of the few chronic pain conditions where supplements have notable trial backing — magnesium malate, CoQ10, vitamin D, and SAMe each have randomized data. If you haven''t had a rheumatology or pain-medicine evaluation, that should come first.

Travel Immunity Kit

travel· 1 shared ingredient

Air travel is an immune-compromise event: dry cabin air dries out mucous membranes, recirculated air increases viral exposure, sleep disruption suppresses immune function, and physical stress raises cortisol. The goal isn't "boost" immunity (a misleading framing) — it's correct any nutrient gaps that would otherwise dim the immune response, and reduce the severity and duration of any infection you do pick up. Vitamin D and zinc are the highest-leverage nutrients here. Vitamin C and quercetin have smaller, supportive roles. This is a 10-day protocol: start 3 days before travel and continue for 7 days after.

Track this protocol in Pilora

Add these supplements to your shelf, get smart dose reminders, and check for interactions — all in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This protocol is educational, not a substitute for personalized medical advice. Talk to your doctor before starting any new supplement regimen — especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition. Last updated 5/20/2026.